SciELO - Scientific Electronic Library Online

 
vol.78 issue2Substance use disorders and attention-deficit/hyperactivity disorder: frequency in male patients at an specializedaddictions hospital ward author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista de Neuro-Psiquiatría

Print version ISSN 0034-8597

Abstract

GUILLEN PINTO, Daniel  and  GUILLEN MENDOZA, Daniel. West Syndrome, experience in a case series with access to first line medication, in Lima. Rev Neuropsiquiatr [online]. 2015, vol.78, n.2, pp.65-72. ISSN 0034-8597.

Objectives: To describe the clinical characteristics of a seriesof patients with West Syndrome (WS) with access to first line medication. Material and Methods: Retrospective observational study of children treated between 1996 and 2014. Results: 37 cases were included, with an average starting age of 6.4 months, predominantly males (75.7%), the majority was from Lima. The most common etiology was secondary (83.8%), as prenatal, brain malformations, Tuberous Sclerosis, Down syndrome and perinatal causes. The WS was controlled in 67.6% of the cases; Vigabatrinand ACTH were effective in 20/32 (62.5%). Two patients were controlled with Levetiracetam, one with Topitamate, one with Lamotrigine and one with surgery. Hypsarrhythmia was the predominant electroencephalographic pattern 23/37 (64.9%). Neurologic comorbidities were very frequent (97.3%) and they were mild only in 7/37 (18.9%). Two patients passed away. Conclusions: In this series, the WS had a secondary cause and was efficiently controlled with Vigabatrin or ACTH, therefore, we recommend their inclusion in the national request

Keywords : West syndrome; children; epilepsy; vigabatrine; ACTH; levetiracetam; Peru.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License